Market Place
Sourcing Support
All News #Library
Biotech
Mannkind Unveils Afrezza Data From Pediatric And Adult Studies
09 Mar 2026 //
GLOBENEWSWIRE
Mannkind Reveals FDA Approval For Afrezza Label Update
26 Jan 2026 //
GLOBENEWSWIRE
Mannkind Submits FUROSCIX Readyflow Autoinjector For Edema in CKD
01 Dec 2025 //
GLOBENEWSWIRE
Mannkind Submits Afrezza sBLA For Pediatric Diabetes To FDA
13 Oct 2025 //
GLOBENEWSWIRE
MannKind to Present Inhaled Insulin Data at ADA`s 85th Sessions
09 Jun 2025 //
GLOBENEWSWIRE
Type 1 Diabetes Patients Achieve A1C Goal With Inhaled Insulin
30 Sep 2024 //
GLOBENEWSWIRE
INHALE-3 Inhaled Insulin vs. Usual Care T1D ADA 84th Session
22 Jun 2024 //
GLOBENEWSWIRE
Dr. Burkhard Blank Joins MannKind as Executive Vice President of R&d & CMO
24 May 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.